OverviewCompetitorsNews & Insights

Cancer Therapeutics CRC Competitors or Alternatives

Cancer Therapeutics CRC 's top competitors include Soricimed Biopharma, Inc., bluebird bio and NexImmune.

Unlock 24 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • CEO

    CEO RATING

    EMPLOYEES

  • FUNDING

    REVENUE

  • CEO

    CEO RATING

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Cancer Therapeutics CRC 's company profile

CEO

- -
1 - 25
$0
$100K - 5M

  • CEO

    - -
    1 - 25
  • $0
    $100K - 5M

  • CEO

    - -
  • 1 - 25
    $0
  • $100K - 5M

  • CEO

  • - -
  • 1 - 25
  • $0
  • $100K - 5M
View ProfileView
1
Cancer Therapeutics CRC 's Competitor - Soricimed Biopharma, Inc. logo

Robert Bruce

CEO

90/100
100 - 250
- -
$100K - 5M

  • Robert Bruce

    CEO

    90/100
    100 - 250
  • - -
    $100K - 5M

  • Robert Bruce

    CEO

    90/100
  • 100 - 250
    - -
  • $100K - 5M

  • Robert Bruce

    CEO

  • 90/100
  • 100 - 250
  • - -
  • $100K - 5M
View ProfileView
2
Cancer Therapeutics CRC 's Competitor - bluebird bio logo

Andrew Obenshain

CEO

58/100
520
$526.4M
$5.1M

  • Andrew Obenshain

    CEO

    58/100
    520
  • $526.4M
    $5.1M

  • Andrew Obenshain

    CEO

    58/100
  • 520
    $526.4M
  • $5.1M

  • Andrew Obenshain

    CEO

  • 58/100
  • 520
  • $526.4M
  • $5.1M
View ProfileView
3
Cancer Therapeutics CRC 's Competitor - NexImmune logo

Kristi Jones

CEO

82/100
70
$162.8M

  • Kristi Jones

    CEO

    82/100
    70
  • $162.8M

  • Kristi Jones

    CEO

    82/100
  • 70
    $162.8M

  • Kristi Jones

    CEO

  • 82/100
  • 70
  • $162.8M
View ProfileView
4
Cancer Therapeutics CRC 's Competitor - Juno Therapeutics logo

CEO

- -
1,000 - 5,000
$1.5B
$100M - 500M

  • CEO

    - -
    1,000 - 5,000
  • $1.5B
    $100M - 500M

  • CEO

    - -
  • 1,000 - 5,000
    $1.5B
  • $100M - 500M

  • CEO

  • - -
  • 1,000 - 5,000
  • $1.5B
  • $100M - 500M
View ProfileView
5
Cancer Therapeutics CRC 's Competitor - TScan logo

David Southwell

CEO

83/100
110
$320M
$13.3M

  • David Southwell

    CEO

    83/100
    110
  • $320M
    $13.3M

  • David Southwell

    CEO

    83/100
  • 110
    $320M
  • $13.3M

  • David Southwell

    CEO

  • 83/100
  • 110
  • $320M
  • $13.3M
View ProfileView
Cancer Therapeutics CRC 's top 27 competitors are Soricimed Biopharma, Inc., bluebird bio, NexImmune, Aura Biosciences, Juno Therapeutics, TScan, Mustang Bio, Adaptimmune, Sangamo, Perthera, Fate Therapeutics, Intellia, Sesen Bio, VelosBio, BMS, CRISPR, FerGene, Novartis, Ember Therapeutics, UroGen, Gilead, Recombinetics, CG Oncology, Centrose, Spark, ImmunityBio and Immunocore. Together they have raised over 15.8B between their estimated 157.5K employees. Cancer Therapeutics CRC 's revenue is the ranked 25th among it's top 10 competitors. The top 10 competitors average 5B. Cancer Therapeutics CRC has 8 employees and is ranked 26th among it's top 10 competitors. The top 10 competitors average 5,832.

Soricimed Biopharma, Inc. is the biggest rival of Cancer Therapeutics CRC . Soricimed Biopharma, Inc. is headquartered in Sackville, New Brunswick, and was founded in 2005. Soricimed Biopharma, Inc. is in the field. Soricimed Biopharma, Inc. generates 2,446% the revenue of Cancer Therapeutics CRC .

bluebird bio is Cancer Therapeutics CRC 's #2 competitor. bluebird bio is a Public company that was founded in Cambridge, Massachusetts in 1992. bluebird bio is in the industry. bluebird bio has 512 more employees vs. Cancer Therapeutics CRC .

NexImmune has been one of Cancer Therapeutics CRC 's top competitors. NexImmune's headquarters is in Gaithersburg, Maryland, and was founded in 2011. NexImmune competes in the field. NexImmune generates NaN% of Cancer Therapeutics CRC 's revenue.

Trending News for Cancer Therapeutics CRC and Cancer Therapeutics CRC 's Competitors

January 27, 2023MarketScreener
(marketscreener.com) By Colin Kellaher Bristol Myers Squibb Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Hum...
January 26, 2023BioPharma-Reporter
The European Medicines Agency (EMA) has validated the marketing authorization application of Vertex Pharmaceuticals and CRISPR Therapeutics for exa-cel...
Today 4:23 AMcentralcharts
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcom...
January 26, 2023Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) today issued the following statement reiterating the Company's confidence in, and com...
January 27, 2023Seeking Alpha
January 27, 2023Medthority
Bristol Myers Squibb announced topline results from ITRANSCEND CLL 004, a Phase I/II, open-label, single-arm, multicenter study evaluating Breyanzi (li...
January 27, 2023PR Newswire
NEW YORK, Jan. 27, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders o...
January 26, 2023BioSpace
Sesen Bio, Inc. (Nasdaq: SESN) today issued the following statement reiterating the Company's confidence in, and commitment to, the pending merger with...
January 27, 2023MarketScreener
(marketscreener.com) Jan 27, 2023 The preliminary results from the ongoing global phase III study STAND indicate no statistically significant differenc...
January 26, 2023Endpoints News
Bristol Myers Squibb is looking to expand Breyanzi into more indications - and the pharma's newest data readout makes progress on that front. The Big P...

Frequently Asked Questions about Cancer Therapeutics CRC

  1. Who are Cancer Therapeutics CRC 's top competitors?

    Cancer Therapeutics CRC 's top 3 competitors are Soricimed Biopharma, Inc., bluebird bio, NexImmune.

  2. Who is similar to Cancer Therapeutics CRC ?

    Soricimed Biopharma, Inc. is the most similar to Cancer Therapeutics CRC . bluebird bio and NexImmune are also similar to Cancer Therapeutics CRC .

  1. Are Cancer Therapeutics CRC and Soricimed Biopharma, Inc. competitors?

    Yes, Soricimed Biopharma, Inc. is one of Cancer Therapeutics CRC ’s top competitors.